Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
13F holders, Q3 2024 (September 30)20holders +2
4new positions
2sold out
$5.92avg. 13F price*
At the end of Q3 2024, 20 institutions reported holding Biomarin Pharmaceutical (bmrn 1.25 05/15/27) in their 13F filings, up 2 from Q2 2024. 4 opened new positions and 2 sold out. The largest holders were Loomis Sayles & Co. L P ($156.1M), Thrivent Financial for Lutherans ($14.1M) and Sonora Investment Management Group, LLC ($8.8M).
- Company
- Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
- CUSIP
- 09061GAK7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $390K |
| Exits | 2 | $988K |
All 13F filers, Q2 2024 → Q3 2024: 1,648,408 shares bought and 1,722,000 shares sold, net −73,592 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Loomis Sayles & Co. L P | 0.21% | Add +2.3% | 2,221,448 | $156.1M |
| Thrivent Financial for Lutherans | 0.03% | Add +8.7% | 14,805,000 | $14.1M |
| Sonora Investment Management Group, LLC | 0.66% | Reduce -6.8% | 9,260,000 | $8.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,900,000 | $2.8M |
| Sei Investments Co. | 0.00% | No change | 524,000 | $498K |
| Mizuho Securities USA LLC | 0.01% | New | 316,000 | $300K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $286K |
| Cetera Investment Advisers | 0.00% | Add +1.0% | 198,000 | $188K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -4.9% | 195,000 | $185K |
| Stephens Inc. | 0.00% | Reduce -6.6% | 99,000 | $94K |
| Cerity Partners LLC | 0.00% | Add +33.5% | 28,028 | $53K |
| Mariner, LLC | 0.00% | New | 42,000 | $40K |
| Rollins Financial Advisors, LLC | 0.01% | New | 37,000 | $35K |
| Choreo, LLC | 0.00% | No change | 25,000 | $24K |
| Comerica Bank | 0.00% | New | 15,000 | $14K |
| Capital Investment Advisors, LLC | 0.00% | No change | 11,000 | $10K |
| DAVENPORT & Co LLC | 0.00% | No change | 10,000 | $10K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 7,000 | $7K |
| Oddo BHF Asset Management Sas | 0.00% | — | 575 | $551 |
| Intellectus Partners, LLC | 0.00% | Add +25.4% | 331 | $316 |
"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 1.25 05/15/27)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 1.25 05/15/27) the manager owns.